Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]
Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Int J Nanomedicine. 2021;16:1313–1330. The authors have advised affiliation 3 on page 1313 is incorrect. The text “Affiliated Hospital of Youjiang Medical College for Nationalities” should read “Affiliated Hospital of...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/4cd834eb3e1941f18d62d0f7ca853c1a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| id |
oai:doaj.org-article:4cd834eb3e1941f18d62d0f7ca853c1a |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:4cd834eb3e1941f18d62d0f7ca853c1a2021-12-02T15:06:16ZNanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum]1178-2013https://doaj.org/article/4cd834eb3e1941f18d62d0f7ca853c1a2021-07-01T00:00:00Zhttps://www.dovepress.com/corrigendum-nanocarriers-mediated-drug-delivery-systems-for-anticancer-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Int J Nanomedicine. 2021;16:1313–1330. The authors have advised affiliation 3 on page 1313 is incorrect. The text “Affiliated Hospital of Youjiang Medical College for Nationalities” should read “Affiliated Hospital of Youjiang Medical University for Nationalities”. The authors apologize for this error. Read the original articleEdis ZWang JWaqas MKIjaz MIjaz MDove Medical Pressarticlenanomaterialsanticancer agentsrecent advancesmultidrug resistancechemotherapy.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 5099-5100 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
nanomaterials anticancer agents recent advances multidrug resistance chemotherapy. Medicine (General) R5-920 |
| spellingShingle |
nanomaterials anticancer agents recent advances multidrug resistance chemotherapy. Medicine (General) R5-920 Edis Z Wang J Waqas MK Ijaz M Ijaz M Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| description |
Edis Z, Wang J, Waqas MK, Ijaz M, Ijaz M. Int J Nanomedicine. 2021;16:1313–1330.
The authors have advised affiliation 3 on page 1313 is incorrect. The text “Affiliated Hospital of Youjiang Medical College for Nationalities” should read “Affiliated Hospital of Youjiang Medical University for Nationalities”.
The authors apologize for this error.
Read the original article |
| format |
article |
| author |
Edis Z Wang J Waqas MK Ijaz M Ijaz M |
| author_facet |
Edis Z Wang J Waqas MK Ijaz M Ijaz M |
| author_sort |
Edis Z |
| title |
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_short |
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_full |
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_fullStr |
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_full_unstemmed |
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum] |
| title_sort |
nanocarriers-mediated drug delivery systems for anticancer agents: an overview and perspectives [corrigendum] |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/4cd834eb3e1941f18d62d0f7ca853c1a |
| work_keys_str_mv |
AT edisz nanocarriersmediateddrugdeliverysystemsforanticanceragentsanoverviewandperspectivescorrigendum AT wangj nanocarriersmediateddrugdeliverysystemsforanticanceragentsanoverviewandperspectivescorrigendum AT waqasmk nanocarriersmediateddrugdeliverysystemsforanticanceragentsanoverviewandperspectivescorrigendum AT ijazm nanocarriersmediateddrugdeliverysystemsforanticanceragentsanoverviewandperspectivescorrigendum AT ijazm nanocarriersmediateddrugdeliverysystemsforanticanceragentsanoverviewandperspectivescorrigendum |
| _version_ |
1718388510176575488 |